BALTIMORE, Sept. 11, 2024 /PRNewswire/ — Previse, a gastrointestinal health company, announced the publication of a study in Diagnostics highlighting the analytical validation of Esopredict, a first-in-class DNA methylation test for identifying patients with precancerous Barrett’s…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.